Related Experiment Video
Updated: Sep 15, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Dual-Pronged Attack: Biomimetic Multi-Functional MOFs for Rheumatoid Arthritis Therapy via Inhibiting Synovial
Meng-Wen Ma1, Kai-Lin He2, Sui Zhou1
1Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics─Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, P. R. China.
Abstract:
Fibroblast-like synoviocytes (FLSs) and synovial macrophages (SMs) contribute significantly to the occurrence and development of rheumatoid arthritis (RA). Although therapeutic strategies targeting FLSs or SMs have achieved certain results, monotherapy often fails to effectively alleviate synovitis. By loading methotrexate (MTX) and glucose oxidase (GOx) in the zinc imidazole framework-8 (ZIF-8) and incorporating with the platinum nanoparticles (Pt NPs) and macrophage membranes, multifunctional probe mZPMG NPs were prepared. The mZPMG NPs can synergistically inhibit the abnormal proliferation of FLSs through drug therapy and starvation therapy, while eliminating excessive reactive oxygen species (ROS) and promoting the polarization of SMs toward M2-type macrophages. Oxygen generated through the ROS scavenging process can enhance the efficiency of the GOx starvation treatment. The in vivo experiments demonstrated that the clinical score of collagen-induced arthritis mice treated with the mZPMG NPs was 72.92% lower than those treated with PBS. Meanwhile, the mice in the mZPMG group exhibited obvious suppression of synovial hyperplasia, inflammatory infiltration, and cartilage erosion. Therefore, this study proposed to adopt a "dual pronged attack" strategy in inhibiting the abnormal proliferation of FLSs and reducing the abundance of SMs to achieve macrophage repolarization, which provides a promising platform for the comprehensive treatment of RA.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

